These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14577482)

  • 1. Synergism between the brushite and hydroxyapatite urinary crystallization inhibitors.
    Costa-Bauzá A; Barceló C; Perelló J; Grases F
    Int Urol Nephrol; 2002; 34(4):447-51. PubMed ID: 14577482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of phytate and pyrophosphate on brushite and hydroxyapatite crystallization. Comparison with the action of other polyphosphates.
    Grases F; Ramis M; Costa-Bauzá A
    Urol Res; 2000 Apr; 28(2):136-40. PubMed ID: 10850638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental model to study sedimentary kidney stones.
    Grases F; Llobera A
    Micron; 1998; 29(2-3):105-11. PubMed ID: 9684348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of crystal growth of hydroxyapatite: a constant composition approach.
    Wilson JW; Werness PG; Smith LH
    J Urol; 1985 Dec; 134(6):1255-8. PubMed ID: 2997488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and identification of some urinary inhibitors of calcium phosphate formation.
    Sutor DJ; Percival JM; Doonan S
    Clin Chim Acta; 1978 Oct; 89(2):273-8. PubMed ID: 213213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cellulose phosphate and sodium phosphate on formation product and activity product of brushite in urine.
    Pak CY
    Metabolism; 1972 May; 21(5):447-55. PubMed ID: 4335734
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro.
    Ryall RL; Harnett RM; Marshall VR
    Clin Chim Acta; 1981 May; 112(3):349-56. PubMed ID: 6263523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Mixtures of Magnesium, Citrate and Phytate as Calcium Oxalate Crystallization Inhibitors in Urine.
    Grases F; Rodriguez A; Costa-Bauza A
    J Urol; 2015 Sep; 194(3):812-9. PubMed ID: 25818031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleation and growth of brushite and calcium oxalate in urine of stone-formers.
    Pak CY; Holt K
    Metabolism; 1976 Jun; 25(6):665-73. PubMed ID: 1272073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of trace metals on the inhibition of calcium oxalate crystallization.
    Muñoz JA; Valiente M
    Urol Res; 2005 Aug; 33(4):267-72. PubMed ID: 15937709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary supersaturation with respect to brushite in patients suffering calcium oxalate lithiasis.
    Berland Y; Boistelle R; Olmer M
    Nephrol Dial Transplant; 1990; 5(3):179-84. PubMed ID: 2113644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytate acts as an inhibitor in formation of renal calculi.
    Grases F; Isern B; Sanchis P; Perello J; Torres JJ; Costa-Bauza A
    Front Biosci; 2007 Jan; 12():2580-7. PubMed ID: 17127264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assay method for the measurement of urinary inhibitors of calcium phosphate formation.
    Sutor DJ; Percival JM
    Clin Chim Acta; 1978 Oct; 89(2):256-72. PubMed ID: 213212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the effects of different substances on the early stages of papillary stone formation.
    Grases F; Garcia-Ferragut L; Costa-Bauzá A; March JG
    Nephron; 1996; 73(4):561-8. PubMed ID: 8856252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian rhythms of urinary saturation levels of calcium oxalate and calcium phosphate in normal male individuals.
    Ogawa Y
    Hinyokika Kiyo; 1993 Sep; 39(9):785-9. PubMed ID: 8213370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple technique for assessing the propensity for crystallization of calcium oxalate and brushite in urine from the increment in oxalate or calcium necessary to elicit precipitation.
    Nicar MJ; Hill K; Pak CY
    Metabolism; 1983 Sep; 32(9):906-10. PubMed ID: 6888271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrochlorothiazide therapy in nephrolithiasis. Effect on the urinary activity product and formation product of brushite.
    Pak CY
    Clin Pharmacol Ther; 1973; 14(2):209-17. PubMed ID: 4348641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.